Jack Antel is a clinical neurologist who coordinates the multiple sclerosis research and treatment program at the Montreal Neurological Institute. He has served as the Scientific Director of the endMS Research and Training Network supported by the MS Society of Canada and as President of the International Society of Neuroimmunology. He is currently president of ACTRIMS and Editor for the Americas of the Multiple Sclerosis Journal.
His research interests include understanding the mechanisms of tissue injury and repair that occur in MS and how these can be therapeutically targeted. He received the 2005 Dystel Award from the National Multiple Sclerosis Society and the American Academy of Neurology.